Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3690

Vertebral Compression Fracture Devices Market by Product (Balloon Kyphoplasty Devices and Vertebroplasty Devices) and Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery) - Global Opportunity Analysis and Industry Forecast, 2014-2022

LI_17669
Pages: 141
Mar 2017 | 2153 Views
face gplus_n
Author's : Prateeksha Kaul
Tables: 26
Charts: 35
twit_n pr_n

Vertebral Compression Fracture Devices Market Overview:

Global Vertebral Compression Fracture Devices Market was valued at $748 million in 2015, and is expected to reach $1,109 million by 2022, supported by a CAGR of 5.7% during the forecast period 2014 - 2022. Vertebral compression fracture (VCF) generally occurs when the block-like part of a single bone of the spine (vertebra) is compressed due to trauma. Vertebral implants are used in the treatment of compression fractures of the spine as they stabilize the fracture and ease pain

Segmentation

Vertebral Compression Fracture Devices Market Segmentation

Get more information on this report : Request Sample Pages

Osteoporosis is the major cause of vertebral compression fractures, accounting for ~85% of all VCF cases. These fractures can also occur due to trauma, multiple myeloma, metastasis, and malignant bone tumors that may cause spine collapse. According to the American Academy of Orthopaedic Surgeons, ~750,000 cases of osteoporosis-related VCFs occur in the U.S. alone. In addition, more than 25% of all menopausal women are affected by VCF in the U.S.; however, approximately two-thirds of these patients do not opt for diagnosis as they consider back pain as a sign of aging and arthritis. Thus, this large undiagnosed patient base provides numerous growth opportunities for this market. VCF is more prevalent in people aged 60 or above, thus the increase in geriatric population and rise in incidence of osteoporosis and arthritis drive the market growth. Moreover, factors such as short recovery period, low risk of infection, and shorter hospital stay are expected to contribute to market growth. However, the risk of post-surgical complications, i.e., hemorrhage, vertebral posterior element fracture, nerve root irritation, and acceleration of osteoporosis; and unfavorable reimbursement scenario may hinder the market growth.

South Africa Vertebral Compression Fracture Devices Market ($Million), 2014-2022

South Africa Vertebral Compression Fracture Devices Market

Get more information on this report : Request Sample Pages

On the basis of product type, VCF devices market is bifurcated into balloon kyphoplasty and vertebroplasty. Vertebroplasty is a minimal invasive and non-surgical procedure used to treat vertebral compression fractures. Therefore, most of the surgeries are performed in ambulatory surgical centers and recovery period gets reduced to 6-12 weeks. In kyphoplasty, a catheter is placed with a balloon into a collapsed vertebral body and is inflated slowly to expand the compressed vertebra to its normal height. The balloon kyphoplasty segment is witnessing a higher demand, and is expected to dominate as the procedure helps to restore vertebral disc height and relieves pain for a minimum of two years.

The key companies operating in the VCF devices market are Alphatec Holdings, Inc., Benvenue Medical, Depuy Synthes (Johnson & Johnson), Globus Medical, Inc., Medtronic plc, Orthovita, Inc., Osseon LLC, Stryker Corporation, VEXIM SA, and Zimmer Biomet Holdings, Inc. The other players operating in this market include Algea Therapies, Spine Wave, Inc., Spirit Spine, Stöckli Medical AG, and VEXIM SA.

Vertebral Compression Fractures Devices Market Key Benefits

  • The study provides an in-depth analysis of the global VCF devices market, with current trends and future estimations, to elucidate the imminent investment pockets.
  • Quantitative analysis from 2014 to 2022 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • The report provides actual historical figures for 2014 and Y-o-Y forecasts from 2016 to 2022, considering 2015 as base.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Vertebral Compression Fracture Devices Market Key Segments

The global spinal VCF devices market is segmented based on product, surgery type, and region.

By Product

  • Balloon Kyphoplasty
  • Vertebroplasty

By Surgery

  • Open Spine Surgery
  • Minimally Invasive Spine Surgery

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence and strategies of companies

3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing elderly population
3.4.1.2. Increasing incidences of arthritis and osteoporosis
3.4.1.3. Technological advancements in the VCF devices
3.4.1.4. Shift towards minimal invasive VCF procedures

3.4.2. Restraints

3.4.2.1. Stringent regulatory approval procedure

3.4.3. Opportunities

3.4.3.1. Emerging markets to drive the demand for VCF devices
3.4.3.2. Popularization of percutaneous vertebral augmentation (PVA) treatment

3.4.4. Impact analysis

3.5. PORTERS FIVE FORCES ANALYSIS

3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry

3.6. GOVERNMENT REGULATIONS

Chapter: 4 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.1.4. Global VCF Device Implantations, By Type
4.1.5. Balloon kyphoplasty devices

4.1.5.1. Market size and forecast

4.1.6. Vertebroplasty devices

4.1.6.1. Market size and forecast

Chapter: 5 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. OPEN SURGERY

5.2.1. Market size and forecast

5.3. MINIMALLY INVASIVE SURGERY

5.3.1. Market size and forecast

Chapter: 6 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. France market size and forecast
6.3.5. Germany market size and forecast
6.3.6. UK market size and forecast
6.3.7. Spain market size and forecast
6.3.8. Italy market size and forecast
6.3.9. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. India market size and forecast
6.4.5. China market size and forecast
6.4.6. Japan market size and forecast
6.4.7. South Korea market size and forecast
6.4.8. Australia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. ALPHATEC HOLDINGS, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating product categories
7.1.4. Business Performance
7.1.5. Key strategic moves and developments

7.2. OSSEON LLC

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Key strategic moves and developments

7.3. ORTHOVITA, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Key strategic moves and developments

7.4. JOHNSON & JOHNSON

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments

7.5. GLOBUS MEDICAL, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Key strategy share

7.6. MEDTRONIC PLC

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Key strategy share

7.7. BENVENUE MEDICAL

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Key strategic moves and developments
7.7.4. Key strategy share

7.8. VEXIM SA

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Key strategic moves and developments
7.8.4. Key strategy share

7.9. STRYKER CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments

7.10. ZIMMER BIOMET HOLDINGS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Key strategy share

LIST OF TABLES

TABLE 1. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICE IMPLANTATIONS, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 3. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY TYPE ($MILLION), 2014-2022
TABLE 4. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR OPEN SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 5. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR MINIMALLY INVASIVE SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 6. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 8. EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 9. ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 10. LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 11. ALPHATEC: COMPANY SNAPSHOT
TABLE 12. ALPHATEC: PRODUCT CATEGORIES
TABLE 13. OSSEON: COMPANY SNAPSHOT
TABLE 14. ORTHOVITA: COMPANY SNAPSHOT
TABLE 15. J&J: COMPANY SNAPSHOT
TABLE 16. J&J: BUSINESS SEGMENTS
TABLE 17. GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 18. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 19. MEDTRONIC: COMPANY SNAPSHOT
TABLE 20. MEDTRONIC: BUSINESS SEGMENTS
TABLE 21. BENVENUE: COMPANY SNAPSHOT
TABLE 22. VEXIM: COMPANY SNAPSHOT
TABLE 23. STRYKER: COMPANY SNAPSHOT
TABLE 24. STRYKER: BUSINESS SEGMENTS
TABLE 25. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 26. ZIMMER BIOMET: BUSINESS SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY TYPE ($MILLION), 2015 VS 2022
FIGURE 2. VERTEBRAL COMPRESSION FRACTURE MARKET SEGMENTATION
FIGURE 3. TOP WINNING STRATEGIES
FIGURE 4. TOP WINNING STRATEGIES, ORGANIC AND INORGANIC
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES
FIGURE 7. TOP INVESTMENT POCKETS
FIGURE 8. MARKET SHARE ANALYSIS, 2015
FIGURE 9. BARGAINING POWER OF BUYERS
FIGURE 10. BARGAINING POWER OF SUPPLIERS
FIGURE 11. THREAT OF SUBSTITUTES
FIGURE 12. THREAT OF NEW ENTRANTS
FIGURE 13. COMPETITIVE RIVALRY
FIGURE 14. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR BALLOON KYPHOPLASTY DEVICES ($MILLION), 20142022
FIGURE 15. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR VERTEBROPLASTY DEVICES ($MILLION), 20142022
FIGURE 16. U.S.: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 17. CANADA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 18. MEXICO: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 19. POPULATION STRUCTURE BY MAJOR AGE GROUPS, EU-28
FIGURE 20. FRANCE: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 21. GERMANY: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 22. UK: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 23. SPAIN: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 24. ITALY: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 25. REST OF EUROPE: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 26. INDIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 27. CHINA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 28. JAPAN: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 29. SOUTH KOREA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 30. AUSTRALIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 31. REST OF ASIA-PACIFIC: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 32. BRAZIL: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 33. SAUDI ARABIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 34. SOUTH AFRICA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 35. REST OF LAMEA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022

 

Globally, vertebral compression fractures constitute a major proportion of health and economic burden; thus, effective VCF devices are necessary to treat compression fractures. VCF surgery is emerging as a significant treatment option, which makes use of VCF devices.

The increasing incidence of vertebral compression fractures has led to high adoption of the VCF devices. In addition, growth in geriatric population, rise in prevalence of lifestyle disorders (obesity), and advent of better VCF devices (balloon kyphoplasty, which helps to restore the disc height) drive the growth of VCF devices market globally.

Advanced spine surgery treatment options are a major driver for market growth. Currently, spine surgeons prefer minimal invasive surgical techniques for a wide range of VCF procedures, as lesser complications are associated with this procedure, such as reduced length of hospital stay and less bleeding.

Geographically, Asia-Pacific offers lucrative growth opportunities, especially emerging economies (such as China & India) for the market due to increase in healthcare expenditure, rise in geriatric population, and high incidence of spine impairments.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Vertebral Compression Fracture Devices Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $3690
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo